Amanote Research
Register
Sign In
Php65 - Analysis of Icer-Estimated Value-Based Prices and Potential Discounts for Drugs in the United States
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.959
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
K. Kloc
M. Dusza
S. Lach
Y. Sediri
C. Rémuzat
M. Toumi
Publisher
Elsevier BV
Related search
Prices Analysis of Osteoporosis Drugs Marketed in the United States (1988-2014)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Analysis of Average Manufacturer Prices of New Drugs Approved in the United States (1990-2012)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Estimated Value of Service Reliability for Electric Utility Customers in the United States
Trends in Approvals and Prices of Oncology Drugs in the United States (1990-2013)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prices of Lilies for 1928 Delivered in the United States /
Value and Payment for Oncology in the United States
Annales Pharmaceutiques Francaises
Pharmacology
Pharmaceutical Science
Intellectual Property and Pharmaceutical Prices in the United States
The Southwest Respiratory and Critical Care Chronicles
Trends in List Prices, Net Prices, and Discounts for Originator Biologics Facing Biosimilar Competition
JAMA network open
Medicine
Commercial and Residential Land Prices Across the United States
SSRN Electronic Journal
